Founder & CEO John Mulligan Shares Bonum Therapeutics’ “No Jerks” Approach to Hiring
LinkedIn
Feb 14, 2023
Blog
News Archive
Seattle biotech startup born out of a Roche buyout lands $93M to advance therapies
GeekWire
Nov 15, 2022
Media
After $250M Roche buyout, a startup plans a second strike with fresh funding
BioPharmaDive
Nov 15, 2022
Media
From Good to Great: Bonum Therapeutics Raises $93M Series A with Allosterically Regulated Medicines
Genetic Engineering & Biotechnology News
Nov 15, 2022
Media
The crew that sold its lead IL-2 program to Roche is back with $93M to work on more next-gen I/O drugs
Endpoints News
Nov 15, 2022
Media